<i>Toxoplasma gondii</i> eIF-5A Modulates the Immune Response of Murine Macrophages In Vitro

<i>Toxoplasma gondii</i> (<i>T. gondii</i>) is an obligate intracellular protozoan that can elicit a robust immune response during infection. Macrophage cells have been shown to play an important role in the immune response against <i>T. gondii</i>. In our previou...

Full description

Bibliographic Details
Main Authors: Xinchao Liu, Xiaoyu Li, Chunjing Li, Mingmin Lu, Lixin Xu, Ruofeng Yan, Xiaokai Song, Xiangrui Li
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/1/101
Description
Summary:<i>Toxoplasma gondii</i> (<i>T. gondii</i>) is an obligate intracellular protozoan that can elicit a robust immune response during infection. Macrophage cells have been shown to play an important role in the immune response against <i>T. gondii</i>. In our previous study, the eukaryotic translation initiation factor 5A (eIF-5A) gene of <i>T. gondii</i> was found to influence the invasion and replication of tachyzoites. In this study, the recombinant protein of <i>T. gondii</i> eIF-5A (r<i>Tg</i>eIF-5A) was incubated with murine macrophages, and the regulatory effect of <i>Tg</i>eIF-5A on macrophages was characterized. Immunofluorescence assay showed that <i>Tg</i>eIF-5A was able to bind to macrophages and partially be internalized. The Toll-like receptor 4 (TLR4) level and chemotaxis of macrophages stimulated with <i>Tg</i>eIF-5A were reduced. However, the phagocytosis and apoptosis of macrophages were amplified by <i>Tg</i>eIF-5A. Meanwhile, the cell viability experiment indicated that <i>Tg</i>eIF-5A can promote the viability of macrophages, and in the secretion assays, <i>Tg</i>eIF-5A can induce the secretion of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and nitric oxide (NO) from macrophages. These findings demonstrate that eIF-5A of <i>T. gondii</i> can modulate the immune response of murine macrophages in vitro, which may provide a reference for further research on developing <i>T. gondii</i> vaccines.
ISSN:2076-393X